{
    "nct_id": "NCT05946824",
    "official_title": "Daily-Adaptive Stereotactic Body Radiation Therapy for Biochemically Recurrent, Radiologic Apparent Prostate Cancer After Radical Prostatectomy",
    "inclusion_criteria": "* Adenocarcinoma of the prostate with previous surgical resection\n* Radiologically detected prostate bed OR regional nodal recurrence defined as iliac, obturator, perirectal or pre-sacral node generally encompassing below the aortic bifurcation\n* Prostate bed recurrence as occurring within the region of the prostate or RTOG consensus definition of the surgical field\n* At least two serum detectable PSA levels defined as >0.02 ng/dl at least 30 days apart.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Metastatic disease\n* Prior radiation therapy to the pelvis region\n* Inflammatory bowel disease\n* Hospitalization for a gastrointestinal diagnosis in the preceeding 3 months\n* Hospitalization for a urinary tract issue / diagnosis in the preceeding 3 months\n* PSA >10 ng/dl at study entry,",
    "miscellaneous_criteria": ""
}